Биохакинг

497

Messina, M. & Redmond, G. (2006). Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid 16 (3): 249–258. Review.

498

Chavarro, J. & Toth, T. & Sadio, S. & Hauser, R. (2008). Soy food and isoflavone intake in relation to semen quality parameters among men from an infertility clinic. Human Reproduction 23 (11): 2584–2590.

499

Grace, P. et al. (2004). Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiological Biomarkers and Prevention 13 (5): 698–708.

500

de Lemos, M. (2001). Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. The Annals of Pharmacotherapy 35 (9): 1118–1121. Review.

501

Johnson, I. & Gee, J. & Price, K. & Curl, C. & Fenwick, G. (1986) Influence of saponins on gut permeability and active nutrient transport in vitro. The Journal of Nutrition 116 (11): 2270–2277.

502

Baumann, E. et al. (2000). Hemolysis of human erythrocytes with saponin affects the membrane structure. Acta Histochemica 102 (1): 21–35.

503

USDA. (2015). Adoption of Genetically Engineered Crops in the U.S. Economic Research Service. [date of reference 1.1.2016]

504

Paul, B. & Snyder, S. (2010). The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death and Differentiation 17 (7): 1134–1140

505

Lindequist, U. & Niedermeyer, T. & Jüllich, W. (2005). The Pharmacological Potential of Mushrooms. Evidence-based Complementary and Alternative Medicine 2 (3): 285–299.

506

Rogers. R. (2011). The Fungal Pharmacy: The Complete Guide to Medicinal Mushrooms and Lichens of North America. North Atlantic Books.

507

Ganeshpurkar, A. & Rai, G. & Jain, A. (2010). Medicinal mushrooms: Towards a new horizon. Pharmacognosy Reviews 4 (8): 127–35

508

Evira. (2010). Myrkylliset sienet. Elintarviketurvallisuusvirasto Evira. [date of reference: 29.11.2014]

509

Evira. (2008). Sienten käsittelyohjeet. Radioaktiivisen cesiumin vähentäminen. STUK ja Evira. [date of reference: 29.11.2014]

510

Часть указанных грибов (некоторые млечники, трутовики и другие грибы) в России относят к условно-съедобным. – Прим. науч. ред.

511

Nieminen, P. & Kirsi, M. & Mustonen, A. M. (2006). Suspected myotoxicity of edible wild mushrooms. Experimental Biology and Medicine 231 (2): 221–228.

512

Beelman, R. & Kalaras, M. (2009). Post-harvest Vitamin D Enrichment of Fresh Mushrooms. HAL Project #MU07018, Penn State University.

513

Gleeson, T. & Wada, Y. & Bierkens, M. & van Beek, L. (2012). Water balance of global aquifers revealed by groundwater footprint. Nature 488 (7410): 197–200.

514

World Water Assessment Programme. (2003). Water for People, Water for Life. The United Nations World Water Development Report. UNESCO. [date of reference: 29.11.2014]

515

Hakulinen, P. (2006). Experimental studies on cellular mechanisms of the carcinogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX). Kansanterveyslaitos, väitöstutkimus. [date of reference: 30.11.2014]

516

Pekkarinen. A. (2014). Putkien syöpyminen on monen talon ongelma. Suomen Kiinteistölehti. [date of reference: 29.11.2014]

517

Vesi- ja viemärilaitosyhdistys. (2009). Kiinteistöjen metallisten käyttövesiputkistojen ja -laitteistojen kestävyys. Tiivistelmäraportti. FCG Planeko OY. [date of reference: 29.11.2014]

518

Kousa, A. et al. (2006). Calcium: magnesium ratio in local groundwater and incidence of acute myocardial infarction among males in rural Finland. Environmental Health Perspectives 114 (5): 730–734.

519

Valsta, L. et al. (2008). Juomat ravitsemuksessa. Valtion ravitsemusneuvottelukunnan raportti. [date of reference: 30.11.2014]

520

Wagner, M. & Oehlmann, J. (2009). Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles. Environmental Science and Pollution Research 16 (3): 278–286.

521

Higdon, J. & Frei, B. (2006). Coffee and health: a review of recent human research. Critical Reviews in Food Science and Nutrition 46 (2): 101–123. Review.

522

Ding, M. et al. (2014). Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37 (2): 569–586.

523

Ding, M. et al. (2014). Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014 129 (6): 643–659.

524

Crippa, A. & Discacciati, A. & Larsson, S. & Wolk, A. & Orsini, N. (2014). Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. American Journal of Epidemiology 180 (8): 763–775.

525

Wang, Y. & Ho, C. (2009). Polyphenolic chemistry of tea and coffee: a century of progress. Journal of Agriculture and Food Chemistry 57 (18): 8109–8114. Review.

526

Djordjevic, N. & Ghotbi, R. & Jankovic, S. & Aklillu, E. (2010). Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. European Journal of Clinical Pharmacology 66 (7): 697–703.

527

Suarez-Quiroz M. et al. (2005). Effect of the post-harvest processing procedure on OTA occurrence in artificially contaminated coffee. International Journal of Food Microbiology 103 (3): 339–345.

528

Viani, R. (2002). Effect of processing on ochratoxin A (OTA) content of coffee. Advances in Experimental Medicine and Biology 504: 189–193. Review.

529

van der Stegen, G. & Essens, P. & van der Lijn, J. (2001). Effect of roasting conditions on reduction of ochratoxin a in coffee. Journal of Agricultural and Food Chemistry 49 (10): 4713–4715.

530

Tullilaboratorio. (2012). Mykotoksiinit. Suomen tulli. [date of reference: 28.11.2014]

531

European Coffee Co-operation. (2006). Quality Control System for Coffee with respect to Occurrence of Ochratoxin A in the coffee chain. European Coffee Co-operation Task Force. [date of reference: 28.11.2014]

532

Hicks, M. & Hsiesh, Y. (1996). Tea preparation and its influence on methylxanthine concentration. Food Research International 29 (3–4): 325–330.

533

Schwalfenberg, G &, Genuis, S. & Rodushkin, I. (2013). The benefits and risks of consuming brewed tea: beware of toxic element contamination. Journal of Toxicology 2013: 370460.

534

Owen, G. & Parnell, H. & De Bruin, E. & Rycroft, J. (2008). The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience 11 (4): 193–198.

535

Peng, X. et al. (2014). Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Scientific Reports 4: 6251

536

Khalesi, S. et al. (2014). Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. European Journal of Nutrition 53 (6): 1299–1311.

537

Onakpoya, I. & Spencer, E. & Heneghan, C. & Thompson, M. (2014). The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutrition Metabolism and Cardiovascular Disease 24 (8): 823–836.

538

Liu, K. et al. (2013). Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. The American Journal of Clinical Nutrition 98 (2): 340–348.

539

Boehm, K. et al. (2009). Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews (3): CD005004. Review.

540

Hodgson, A. & Randell, R. & Jeukendrup, A. (2013). The effect of green tea extract on fat oxidation at rest and during exercise: evidence of efficacy and proposed mechanisms. Advances in Nutrition 4 (2): 129–40. Review.

541

Giulian, R. et al. (2007). Elemental characterization of commercial mate tea leaves (Ilex paraguariensis A. St.-Hil.) before and after hot water infusion using ion beam techniques. Journal of Agriculture and Food Chemistry 55 (3): 741–746.